& Tschop, M
Faerch K, Torekov SS, Vistisen D, Johansen NB, Witte DR, Jonsson A, et al
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
We proudly serve clients locally across Wisconsin and nationally through our telehealth programs , delivering physician-led, data-driven care designed to help you look, feel, and perform at your best
Published 2016 Oct 12
Cells that have undergone ferroptosis remain at their normal nuclear size, without showing a lack of chromatin condensation, nuclear fragmentation, membrane blebbing, or formation of small vesicles known as apoptotic bodies, which are the signature morphological changes in apoptosis (Dixon et al., 2012